Sabinsa, the globally renowned research-oriented supplier known for its sustainable and innovative nutraceutical and cosmeceutical ingredients, will highlight LactoSpore Weizmannia coagulans at the Expanding the Lineup: Next Probiotics and Supplement Spring Symposium hosted by the Korean Society for Lactic Acid Bacteria and Probiotics in Seoul, Korea on May 24, 2024.

Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, will be exhibiting at the International Food Ingredients & Additives (IFIA) Expo from May 22–24, 2024, at the Tokyo Big Sight Exhibition Center. The expo primarily focuses on functional foods, dietary supplements, and natural ingredient categories, and is a significant platform for food ingredient manufacturers.

Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, will showcase the company’s portfolio of innovative ingredients at Vitafoods Europe 2024 from 14th to 16th May, at the Palexpo SA International Exhibition Center in Geneva, Switzerland. As the official curcumin sponsor of the event, Sabinsa will highlight its revolutionary product, C3 Reduct® - the only EFSA-approved curcuminoid product in the European market.

Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, will introduce a new product in booth # 1418 at the New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day at the Jacob Javits Center in New York May 1 – 2, 2024. Dr. Anurag Pande, Sabinsa’s VP of Scientific Affairs, will give a presentation designed to guide those brands seeking to add natural, sustainable ingredients to their formulas.

Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, announces Dr. Anju Majeed as Sami-Sabinsa Group Executive Chairperson, assuming the role her father held until his death on March 13, 2024. The company also announced Shaheen Majeed as Global Managing Director & CEO.

Sami-Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 36 years ago, will be highlighting new clinical studies on Shagandha™ (Ashwagandha root extract 2.5% USP grade) for stress and anxiety in booth # 4253 at Expo West in Anaheim, CA March 13 – 16, 2024.

Sabinsa, the multi-national health science company founded 35 years ago by Dr. Muhammed Majeed, announces that Curcumin C3 Reduct® has been approved by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list. This approval allows introduction and commercialization of C3 Reduct®, most active metabolite of curcumin, in food and supplements in Brazil. Approval is based on a dossier submitted to ANVISA detailing safety and efficacy of a product. C3 Reduct® is the only Tetrahydrocurcuminoids approved in this market. C3 Reduct® was given approval at dosage of 120mg/day.

Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, will begin the new year by relocating the Sabinsa Nanjing Biotechnology Company Limited corporate office to a new location in Nanjing, China. In addition to office space, the company will have a sizeable warehouse, repacking, QC, and meeting rooms on the premises. .

Sami-Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, announces the most recent clinical study on its branded 2.5% USP grade Ashwagandha root ingredient: Shagandha. The study, published in the journal Medicine, suggested that Shagandha can effectively reduce stress and anxiety by decreasing cortisol and increasing serotonin in healthy individuals with mild to moderate stress-related symptoms, compared to placebo.